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It has long been known that muscle repair potential is 
increasingly compromised with age [1,2], and that this 
age-related defect is associated with reduced activity of 
muscle satellite cells [1,2,3,4] and with the presence of 
chronic, low grade inflammation in muscle [5]. Working 
from the hypothesis that a heightened inflammatory tone 
in aged muscle could contribute to poor regenerative 
capacity, we developed genetic systems to alter in-
flammatory gene expression in satellite cells or muscle 
fibers by modulating the activity of nuclear factor κB 
(NF-κB), a master transcriptional regulator of 
inflammation whose activity is upregulated in many cell 
types and tissues with age [6,7].  
 
The NF-κB transcription factor plays a central role in 
multiple systemic and cellular processes [8]. Activation 
of NF-κB via the classical, or canonical, pathway is 
triggered by pro-inflammatory signals and involves its 
release from an inhibitory interaction with cytoplasmic 
inhibitor of kappa B (IκB) [9]. This release is initiated 
by a phosphorylation and degradation cascade that 
activates the IκB kinase β (IKKβ), which in turn 
phosphorylates IκB and stimulates its ubiquitination and 
degradation [9]. In the absence of IκB, NF-κB trans-
locates to the nucleus where it regulates expression of 
genes involved in proliferation, differentiation, 
migration and regulation of the immune and 
inflammatory systems [10]. NF-κB activation via the 
alternative  pathway  similarly  requires  degradation  of  
IκB, but occurs independent of IKKβ activity. 























Skeletal muscle  is a highly  regenerative  tissue, but muscle  repair potential  is  increasingly compromised with
advancing age.  In this study, we demonstrate that increased NF‐κB activity in aged muscle fibers contributes to





salicylate, an FDA‐approved NF‐κB  inhibitor, decreased  inflammatory gene expression and  improved repair  in
aged muscle. Together,  these studies  identify a unique NF‐κB  regulated, non‐cell autonomous mechanism by
which  stem  cell  function  is  linked  to  lipid  signaling and homeostasis,  and provide  important new  targets  to
stimulate muscle repair in aged individuals. 
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In skeletal muscle, NF-κB activation has been 
associated with a variety of degenerative and malignant 
muscle disorders, including muscular dystrophy, 
cachexia and rhabdomyosarcoma [10]. Canonical NF-
κB signaling is activated in proliferating myoblasts and 
appears to repress myoblast differentiation, in part by 
inhibiting expression of the myogenic transcription 
factor MyoD [11,12]. In contrast, the alternative 
pathway is activated during myoblast fusion to form 
multinucleated myotubes, where it may regulate 
mitochondrial biogenesis [13]. Tonic activation of 
canonical NF-κB signaling in muscle fibers drives 
progressive muscle atrophy, in part by upregulation of 
the E3 ubiquitin ligases MURF and MAFbx [14,15]. 
Conversely, inhibition of NF-κB activity in a variety of 
cell types, including macrophages and myofibers, can 
reduce inflammation and fibrosis and accelerate repair 
after muscle injury [16,17].  
 
Here, we investigate the particular role of canonical NF-
κB signaling in the loss of muscle regenerative potential 
that typically occurs during normal aging. These studies 
reveal that selective activation of NF-κB activity in 
muscle fibers drives dysfunction of regenerative muscle 
satellite cells and that life-long inhibition of NF-κB 
activity in myofibers preserves muscle repair potential 
with aging via cell-non-autonomous effects on satellite 
cell function. Further analysis of differential gene 
expression in muscles with varying NF-κB activity 
identified a secreted phospholipase (PLA2G5) as a 
myofiber-expressed, NF-κB-regulated gene that governs 
muscle regenerative capacity with age. These data 
suggest a model in which NF-κB activation in muscle 
fibers increases PLA2G5 expression and drives the 
impairment in regenerative function characteristic of 
aged muscle.  Importantly, inhibition of NF-κB function 
reverses this impairment, suggesting that FDA-
approved drugs like salsalate, which diminish NF-κB 
activity, may provide new therapeutic avenues for 
elderly patients with reduced capacity to recover 




Increased NF-κB activity in myofibers and 
myotubes, but not in satellite cells alone, 
impairs satellite cell function 
 
Age-associated deficiencies in muscle repair slow 
recovery of muscle function and promote replacement 
of damaged myofibers with fat and fibrous tissue rather 
than newly formed muscle [2,3].  Based in part on 
studies in mice and humans suggesting that a pro-
inflammatory microenvironment impairs physiological 
function [14,18,19] and limits repair potential in aged 
muscle [20], we hypothesized that alterations in 
canonical NF-κB signaling may underwrite some of the 
functional changes induced in muscle during aging. 
Consistent with this hypothesis, muscle satellite cells 
isolated by fluorescence activated cell sorting (FACS,  
Fig. S1) from aged (24 months old) mice showed 
substantially increased expression of many genes that 
are either direct targets or activators of the NF-κB 
pathway, including interleukin 6 (Il-6), Il-33, 
chemokine-chemokine ligand 2 (Ccl-2), and cyclo-
oxygenase 2 (Cox-2), when compared to young (2-3 
months old) mice (Fig. S2A).  Similar to previous 
reports [3,4,21,22,23], satellite cells were reduced in 
frequency in aged muscle (Fig. S1, S2B) and exhibited 
substantially impaired myogenic activity when 
compared to similarly isolated young cells (Fig. S2C). 
These data thus correlate up-regulation of NF-κB 
activity in muscle satellite cells with decreased 
myogenic potential, suggesting that deregulated NF-κB 
activation may inhibit satellite cell regenerative 
functions in aged muscle. However, upregulation of 
NF-κB signaling is not unique to aged satellite cells. 
Prior studies have reported heightened NF-κB activity 
in sarcopenic muscle [6,19,24], and electrophoretic 
mobility shift assays (EMSA) confirmed increased 
DNA binding activity of NF-κB in muscle fibers from 
aged mice (Fig. S2D,E). Therefore, to determine if 
greater NF-κB activity in aged satellite cells themselves 
might directly impair their regenerative function, we 
generated a bi-allelic Cre-lox transgenic mouse in 
which NF-κB can be activated specifically in muscle 
satellite cells following administration of tamoxifen. 
This system is similar to that used previously by 
Guttridge and colleagues to evaluate NF-κB activities in 
satellite cells during muscle wasting in young, tumor-
bearing cachectic mice and during muscle growth in 
neonatal animals [5]. 
 
Mice carrying the satellite cell-specific tamoxifen-
inducible Pax7-CreER transgene [25] were crossed with 
mice carrying a Cre-inducible bicistronic IKKβca-IRES-
eGFP sequence (encoding a constitutively active (ca) 
form of IKKβ and eGFP) with upstream loxP-flanked 
STOP cassette driven by the Rosa26 promoter [26] (Fig. 
1A). Tamoxifen injection in these bi-allelic “SC-IKK” 
mice (named for ‘satellite cell’ specific IKKβ production) 
induced IKKβca-IRES-eGFP expression in the majority 
of satellite cells, as assessed by GFP expression (Fig. S3). 
Consequent expression in these cells of constitutively 
active IKKβca, which ensures continuous degradation of 
IκB and release of NF-κB from its inhibitory complex 
[26], potently induced the expression in satellite cells of 
multiple NF-κB regulated inflammatory genes (Fig. 1B). 
Importantly, this induction could be rescued by systemic 
treatment with the NF-κB inhibitor sodium salicylate 
[27], confirming involvement of NF-κB activation in this 
perturbation of the satellite cell transcriptome (Fig. 1B).  

















































































































Figure 1. Satellite cell‐specific increase of NF‐κB activity impairs regenerative function in vivo, but does not affect satellite
cell  function  in vitro.  (A) Biallelic SC‐IKK mice contain a  satellite cell  specific Pax7‐CreER allele and a Cre‐inducible  loxP‐flanked STOP
sequence  with  downstream  bicistronic  IKKβca‐IRES‐eGFP  allele  under  control  of  the  Rosa26  promoter.  Exposure  of  SC‐IKK  mice  to
tamoxifen  for 5 consecutive days  induces Cre activity  in satellite cells and causes satellite cell‐specific expression of constitutively active
IKKβ,  leading  to a  satellite  cell‐specific  increase  in NF‐κB activity. All mice  received  sodium  salicylate  feed or  control  feed  starting at 2
months of age. Two weeks  later, mice were  injected with vehicle (corn oil) or tamoxifen, and underwent cryoinjury after an additional 4
weeks.  (B) Quantification  of mRNA  levels  of NF‐κB  target  gene  expression  by  qRT‐PCR  in  satellite  cells  isolated  from  young WT mice
receiving control (n=6 mice) or sodium salicylate feed (n=6 mice), or SC‐IKK mice receiving control (n=5 mice) or sodium salicylate feed (n=5
mice). P‐values calculated by one‐way ANOVA.  (C, D) Quantification of  regenerating  (centrally‐nucleated) myofiber  size  in TA muscles 7
days after cryoinjury for WT mice receiving control feed (n=7 mice) or SC‐IKK mice receiving control (n=7 mice) or sodium salicylate feed
(n=6 mice). Mice with  sodium  salicylate  treatment  continued  receiving  salicylate  feed  during  recovery  after  injury. Data  presented  as
histograms of fiber size (binned by 100 μm2 increments, C or as average fiber cross‐sectional area (mean ± s.e.m., D). P‐values determined
by Kruskal‐Wallis test with step‐down Bonferroni method for (C) and (D). (E) Representative H&E staining of TA muscle sections at 7 days
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To assay the impact of constitutive NF-κB activation in 
satellite cells on muscle regeneration, we challenged 
tamoxifen-treated SC-IKK mice by cryoinjury, which 
induces necrotic cell death of a select region of muscle 
(typically ~20% in our studies), and activates satellite 
cells in the surrounding tissue to nucleate repair 

















































ly cryodamaged muscles revealed a clear deficit in 
repair in tamoxifen-treated SC-IKK mice, evidenced by 
reduced cross-sectional area of newly formed fibers 
(marked by central nuclei, Fig. 1C-E) at day 7 after 
injury. This regenerative defect was largely ameliorated 
by administration of sodium salicylate prior to injury 

















































Figure 2. Muscle fiber‐specific transgenic inhibition of NF‐κB activity improves satellite cell function in an aging
model. (A, B) Distribution and average of cross‐sectional area of regenerating (centrally nucleated) fibers in injured TA muscle
of young  (n=6 mice) or aged WT  (n=7 mice), or aged MISR mice  (n=7 mice) at 7 days after  cryoinjury. Data  represented as
histograms  of  fiber  size  (A)  or  as mean  ±  s.e.m.  (B).  P‐values  calculated  by  Kruskal‐Wallis  test with  Step‐down  Bonferroni
method. (C) Representative H&E staining of muscle sections taken 7 days after cryoinjury in young WT, aged WT or aged MISR
mice. Scale bars, 100 μm. (D) Myogenic colony forming efficiency of satellite cells from young (n=5 mice) or aged (n=5 mice) WT
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vement of heightened NF-κB activity in the observed 
phenotype. Surprisingly, satellite cells isolated from 
SC-IKK mice prior to injury showed no differences in 
frequency (Fig. 1F) or in their intrinsic ability to initiate 
and expand myogenic colonies in single-cell culture 
(Fig. 1G, Fig. S4, colony number and size scored at day 
5 after single cell seeding). However, when satellite 
cells were seeded at greater numbers (1000 cells per 
well) and allowed to differentiate for 7-8 days, so that 
they formed multinucleated myotubes, we found that 
cultures from uninjured SC-IKK mice contained fewer 
nuclei as compared to cultures from wildtype (WT) 
controls (Fig. 1H, Fig. S5). These data suggested that 
the presence of multinucleated derivatives of SC-IKK 
satellite cells may have a negative impact on the 
proliferation or survival of these cells, consistent with 
potential paracrine signaling among SC-IKK muscle 
cells. In further support of this notion, the myogenic 
activity of SC-IKK satellite cells was markedly reduced 
when these cells were isolated from injured muscle 
(Fig. 1I). Thus, based on these data, we contemplated 
the possibility that incorporation of nuclei from NF-κB 
activated SC-IKK satellite cells into regenerated muscle 
fibers in vivo, or myotubes in vitro, creates an NF-κB-
activated niche that negatively impacts the further 
myogenic function of resident muscle satellite cells. In 
such a model, activation of NF-κB signaling in aged 
muscle fibers, rather than aged satellite cells, would 
represent the primary cause of deficient muscle 
regeneration in older animals. 
 
Muscle fiber-specific blockade of NF-κB activity 
improves satellite cell function in aging mice  
  
One possible strategy to test the hypothesis that 
activation of NF-κB in muscle fibers rather than in 
satellite cells is a critical driver of age-associated 
defects in muscle regenerative potential would be to use 
a muscle-specific Cre driver to activate the same 
IKKβca allele in muscle fibers. In fact, such animals 
have been generated using the muscle fiber-specific 
muscle creatine kinase- (MCK-) Cre allele [14] ; 
however, analysis of skeletal muscle in these “MIKK” 
animals (for muscle fiber specific IKKβ production) 
revealed a profound muscle wasting phenotype, which 
would likely confound any evaluation of satellite cell 
number or function in these animals. Therefore, to 
evaluate the importance of muscle fiber-specific 
activation of NF-κB signaling in muscle aging, we took 
a converse approach, examining satellite cell and 
muscle regenerative function in aged “MISR” mice, 
which harbor a transgene that dominantly blocks NF-κB 
signaling in skeletal muscle fibers (but not satellite 
cells) via constitutive expression of the IκB super-
repressor (ISR) under the MCK promoter (Fig. S6A). 
MISR mice exhibit nearly complete inhibition of NF-κB 
activity in mature myofibers in young [14] and aged (24 
month) animals (Fig. S6B,C). Life-long inhibition of 
NF-κB in MISR mice protected these animals from age-
related loss of muscle regenerative potential, as 
indicated by an increased caliber of regenerating fibers 
following cryoinjury in aged MISR mice as compared 
to age-matched wild-type controls (Fig. 2A-C). 
Improved regeneration in aged MISR mice was 
accompanied by an improvement in satellite cell 
myogenic activity (Fig. 2D), although age-related 
reductions in satellite cell frequency were unaffected 
(Fig. 2E). No differences were noted in muscle repair or 
in satellite cell activity or frequency in young MISR 
mice, compared to littermate controls (Fig. S7).  Thus, 
modulating NF-κB regulated gene expression in mature 
muscle fibers produces a cell-non-autonomous impact 
on resident satellite cells, consistent with a local “niche” 
effect of aging on satellite cell function. 
 
Decreased pla2g5 expression in myofibers improves 
muscle regeneration in aged mice 
 
To identify factors that may mediate the NF-κB-
regulated influence of the aged niche on muscle satellite 
cells, we performed a gene array study of whole skeletal 
muscle collected from young WT, aged WT, or aged 
MISR mice. Gene expression comparisons uncovered a 
group of genes that were expressed similarly in young 
WT and aged MISR mice, but differentially expressed 
in aged WT mice (Table S1). Many of these genes 
contained predicted NF-κB binding sites within their 
promoter regions [29] (Table S1). Among the 
candidates, PLA2G5 stood out as a secreted protein 
with functional similarity to snake venom myotoxins 
that can induce inflammation in neighboring cells 
[30,31].  Quantitative PCR analysis confirmed increased 
pla2g5 expression in aged WT muscle and reduced 
expression in aged MISR muscle (Fig. 3A). Although 
present at substantially lower levels than in whole 
muscle tissue, pla2g5 was also expressed in muscle 
satellite cells, with higher levels in aged WT and young 
SCIKK mice and lower levels in young WT and aged 
WT mice treated with salicylate (Fig. 3B). We therefore 
tested whether inhibition of pla2g5 expression in 
muscle might be sufficient to restore muscle 
regeneration in aged mice.  
 
Using in vivo electroporation [32], pla2g5 siRNA was 
co-delivered with mCherry fluorescent protein-
expressing plasmid into tibialis anterior (TA) muscles 
of aged mice (Fig. 3C). The contralateral muscles of the 
same mice were electroporated with a control siRNA 
(containing no significant sequence similarity to mouse, 
rat, or human gene sequences) (Fig. 3C). Electroporated 
muscles were cryoinjured 1 day after electroporation, 
and evaluated for regeneration after an additional 7 
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days. Electroporation efficiency in these studies ranged 
from ~30-70% (as determined by %mCherry+ fibers), 
and gene knockdown, measured at harvest, was 51.9% 
on average (S.D. ± 24.1, Fig. 3D). Thus, the level of 
reduction of pla2g5 mRNA achieved in this system is 
comparable to the difference observed in skeletal 
muscle of young versus aged mice (see Fig. 3A). 
Muscle regeneration was markedly improved in pla2g5 
knockdown muscles, which showed improved histology 
(Fig. 3E) and an increased caliber of regenerating fibers 
(Fig. 3F,G). These data suggest that up-regulation of 
pla2g5 may be one mechanism by which NF-κB 
activation in aged muscle fibers inhibits satellite cells 










































Overall, these in vivo experiments indicate in two 
complementary transgenic models (one gain-of-function 
and one loss-of-function) a cell-non-autonomous 
inhibitory effect of increased transcriptional activity of 
NF-κB in muscle fibers on satellite cell function, 
mediated at least in part by PLA2G5. These data 
additionally suggest that restraining NF-κB activity 
throughout life may protect against some age-acquired 
defects in satellite cell activity and muscle regeneration.  
 
Systemic sodium salicylate treatment improves 
myogenic function of aged satellite cells  
  











































Figure 3. Inhibition of pla2g5 expression improves muscle regeneration in aged mice. (A, B) Expression of pla2g5, normalized
to β‐actin in (A) muscle tissues of young and aged WT and young and aged MISR mice (n=6 mice per experimental group), and (B) satellite
cells  isolated  from  young and aged WT,  aged WT  treated with  sodium  salicylate,  and  young  SCIKK mice  (n=4 mice per experimental
group), determined by quantitative RT‐PCR. Data presented as mean ± s.e.m.; p‐values calculated by one‐way ANOVA. (C) Experimental
design. siRNA and mCherry plasmid were co‐delivered to aged myofibers by in vivo electroporation. Muscles were damaged by cryoinjury
1 day  after electroporation,  and  regenerating myofiber  size was measured 7 days  after  cryoinjury.  Electroporation efficiency  in each
sample was assessed by analysis of mCherry‐expressing myofibers. Scale bars = 500  μm.  (D) Efficiency of gene knockdown by pla2g5
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observations, we next sought to determine whether 
acute, pharmacological inhibition of NF-κB signaling 
might also be effective for reversing age-related deficits 
in muscle repair. We therefore placed aged WT mice 
(24 months) on high-dose sodium salicylate or control 
diet for 6 weeks.  Prior studies demonstrate that high-
dose salicylate therapy is safe in mice and humans and 
effective in reducing NF-κB mediated inflammation 
[14,27,33]. In prior studies, systemic administration of 
sodium salicylate in mice decreased muscle atrophy 
caused by myofiber-restricted overexpression of IKKβ 
[14]. However, what role, if any, sodium salicylate 
might play in modulating muscle regeneration was not 
studied. 
 
EMSAs performed on whole hind limb muscle 








































salicylate-treated aged mice (Fig. S8A,B), and satellite 
cells from these mice similarly displayed evidence of 
reduced NF-κB transcriptional response (Fig. S8C). 
Similar to results obtained in aged MISR mice, satellite 
cells from salicylate-treated aged WT mice showed 
improved myogenic colony forming ability (Fig. 4A), 
but no change in satellite cell frequency (Fig. 4B, Fig. 
S9). Aged mice receiving sodium salicylate also showed 
improved muscle regeneration at early time points after 
cryoinjury (day 7 post-injury, Fig. 4C-E), although this 
difference was lessened at later time points (day 14 
post-injury; Fig. S10). In contrast, young mice and aged 
MISR mice given sodium salicylate did not exhibit 
noticeable differences in muscle regeneration after 
cryoinjury or in the in vitro myogenic activity of satellite 
cells (Fig. S11, S12, Fig. 1F,G), as expected given their 








































Figure  4.  Sodium  salicylate  partially  reverses aging‐associated skeletal muscle inflammation  and  improves myogenic




receiving control or salicylate  feed  for 6 weeks prior to  injury. Salicylate treatment group continued on salicylate  feed during recovery
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Taken together, data presented here suggest that chronic 
inflammatory signaling in muscle fibers, mediated by 
NF-κB, retards the myogenic potential of satellite cells 
in aged muscle. Although NF-κB target genes are 
activated in satellite cells of aged mice, and in mice 
harboring a satellite cell-specific IKKβca transgene, 
these satellite cells exhibited no apparent cell-intrinsic 
defects in frequency or function. Defective satellite cell 
function in the context of induced NF-κB activity was 
revealed only when these cells were exposed to mature 
muscle fibers or myotubes harboring heightened NF-κB 
signaling (either in aged mice or when SC-IKK nuclei 
were incorporated  into  regenerating  myotubes/myo- 
fibers during muscle differentiation and repair). 
Importantly, these results should not be taken as 
evidence that satellite cells are completely unaffected by 
cell-intrinsic elevation of NF-kB signaling. Indeed, 
activation of NF-kB in young satellite cells clearly 
alters their transcriptional program (Fig. 1B) and 
perturbs their performance in differentiation cultures, 
which could reflect either cell autonomous or non-
autonomous effects (see Fig. S5). Nonetheless, our 
results are highly consistent with a critical role for cell-
extrinsic regulation of satellite cell function in these 
contexts, a notion that is further supported by the 
observation that aged MISR mice, which maintain 
dominant inhibition of NF-κB function in muscle fibers 
alone, are partially protected from age-dependent loss of 
satellite cell function.  
 
Our data further suggest that NF-κB may exert its 
effects via PLA2G5, a secreted phospholipase whose 
expression is increased in aged muscle fibers. PLA2G5 
is known to act on lipoprotein and phosphomembrane 
substrates and can release key lipid mediators including 
free fatty acids, lysophospholipids and arachidonic acid, 
a precursor to eicosanoid signaling [34]. Thus, 
increased PLA2G5 in muscle may act directly on 
satellite cell membranes, or indirectly on acellular lipids 
or membranes of other cell types residing in the satellite 
cell niche, to liberate lipid signaling molecules that 
inhibit muscle regeneration. While determination of the 
precise lipid mediators involved remains a subject for 
future studies, it is intriguing to note that elevated levels 
of prostaglandin E2 (PGE2), a classic eicosanoid 
produced by the sequential action of cyclooxygenase 
and terminal prostaglandin E synthase on arachidonic 
acid, have been reported to contribute to defective 
differentiation of human myoblasts from myotonic 
dystrophy type 1 (DM1) patients with large CTG repeat 
expansions [35]. Interestingly, levels of PGE2 are also 
elevated in muscle extracts from aged mice (Fig. S13), 
consistent with an enhanced production of the PGE2 
precursor arachidonic acid as a result of increased 
expression by aged muscle fibers of PLA2G5. 
However, as the specific effects of PGE2 on satellite 
cells and muscle regeneration were not evaluated here, 
the impact on muscle aging of this particular effector, 
and of the multitude of other lipid mediators generated 
by PLA2G5, remain important topics for future 
investigation.  
 
Our results are consistent with prior studies implicating 
NF-κB induction in diminished muscle regeneration in 
cachectic [5] and dystrophic [17] mice, and in response 
to the pro-inflammatory cytokine TWEAK [36]. Of 
particular note, a prior report showed that transplanted 
satellite cells contribute less robustly to muscle repair 
when these cells are introduced into the muscle of 
tumor-bearing mice, which have increased NF-κB 
activity in myofibers [5], although this study did not 
specifically distinguish cell-intrinsic from extrinsic 
contributions of NF-κB signaling in this context. 
Another study evaluated NF-κB activity in the 
dystrophic muscles of mdx mice, and found that 
conditional deletion of IKKβ in activated macrophages 
or muscle fibers impeded regeneration in this system 
[37].  Our study similarly reveals a non-cell-
autonomous regulation of satellite cell regenerative 
function by NF-κB driven gene expression in myofibers 
in aged muscle, and identifies PLA2G5 as a potential 
novel mediator of this effect. Whether PLA2G5 is 
similarly induced in cachectic and dystrophic muscle, as 
it is in aging muscle, will be an interesting area for 
future research. It will also be important to further 
interrogate the molecular circuitry that drives elevated 
NF-κB activity in aged muscle fibers, possibly through 
the generation of inducible alleles that allow 
perturbation of various NF-κB signaling components in 
aged myofibers, and to determine whether other NF-κB 
driven mechanisms, such as elevated TNFα or IL-6 
production, implicated in the deregulation of satellite 
cell function in dystrophic and cachectic muscle, also 
contribute to satellite cell dysfunction in aged muscle 
[38].  This is particularly relevant, as increased 
circulating levels of TNFα and IL-6 have been reported 
in aged individuals [39,40].   
 
The role of anti-inflammatory therapy for the treatment 
of skeletal muscle dysfunction in elderly patients is a 
subject of ongoing investigation [41,42].  It has been 
shown that, following 12 weeks of exercise, NSAID 
therapy modestly increased muscle strength without 
hypertrophy in patients with osteoarthritis of the knee 
[43].  Trappe et al. have further suggested that NSAID 
treatment enhances muscle mass and strength during 
resistance training in older individuals, potentially by 
decreasing PGE2 levels in skeletal muscle [41,44,45]. 
Finally, our observation that high-dose sodium 
salicylate improves regeneration of aged muscle 
suggests that, similar to Losartan, the only other FDA-
approved drug that has shown promise at a basic 
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science level as a therapeutic agent [46], salsalate 
should similarly be considered as a potential 
pharmacologic therapy to boost recovery after muscle 
damage in elderly individuals.  
 




Young (2–3 month) and aged (24 month) C57BL/6 
mice were obtained from pathogen-free breeding 
colonies at Jackson Laboratories and Charles River 
Labs. MISR (a kind gift from S. Shoelson [14], and 
Pax7Cre-ER mice (a kind gift from C. Keller [25] were 
bred in house; loxP-STOP-loxP-IKKβ (C57BL/6-
Gt(ROSA)26Sortm1(Ikbkb)Rsky/J) mice were purchased 
from Jackson Labs. Fidelity of the Pax7-CreER line for 
satellite cell-specific gene expression has been validated 
previously [25]. Tamoxifen (0.1 mg /g body weight, 
Sigma Aldrich) or corn oil vehicle (10 μl /g body 
weight) was injected for 5 consecutive days. For sodium 
salicylate treatment, a feed containing 3 grams of 
sodium salicylate (Sigma Aldrich) per kg was created 
by Research Diets, and purchased along with control 
feed containing the same nutritional content but lacking 
salicylate. Mice were provided sodium salicylate or 
control feed ad libitum for 6 weeks prior to experimen-
tation, including two weeks prior to tamoxifen 
treatment. For injury experiments on salicylate-treated 
mice, animals were continued on salicylate feed during 
recovery after injury (7 days or 14 days). Animals were 
housed at the Biomedical Research Institute at Harvard 
University and the animal facility at the Joslin Diabetes 
Center. Animal procedures conducted in this study were 
reviewed and approved by Institutional Animal Care 
and Use Committees (IACUC) at Harvard’s Faculty of 
Arts and Sciences and at the Joslin Diabetes Center.  
 
Satellite cell isolation 
 
Single myofibers and myofiber-associated cells were 
prepared from two-step collagenase/dispase digestion of 
intact limb muscles (EDL, gastrocnemius, quadriceps, 
soleus, TA, and triceps brachii), as previously described 
[4,21,47,48].  All myofiber-associated cells were 
incubated in Hank’s Buffered Salt Solution (Gibco) 
containing 2% donor bovine calf serum on ice for 20 
min with the following antibodies: anti-mouse CD45 
(1:200, clone 30-F11, Biolegend Cat #103106 for PE 
conjugate, or Biolegend Cat#103115 for APC/Cy7 
conjugate); anti-mouse/human CD11b (1:200, clone 
M1/70, Biolegend Cat# 101208 for PE conjugate, or 
Biolegend Cat#101226 for APC/Cy7 conjugate); anti-
mouse Ter119 (1:200, Biolegend Cat#116208 for PE 
conjugate, or Biolegend Cat#116223 for APC/Cy7 
conjugate); APC conjugate anti-Ly-6A/E (Sca-1) 
(1:200, clone D7, Biolegend #108112); anti-mouse 
CD29 (β1-integrin) (1:200, clone HMB1-1, BD 
Pharmingen Cat# 102202; or 1:100, Biolegend 
Cat#102208 for PE conjugate); FITC conjugate anti-
armenian hamster IgG (1:100, eBioscience Cat#11-
4111-85); biotinylated anti-mouse CD184 (CXCR4) 
(1:100, BD Pharmingen Cat#551968); and PE/Cy7 
conjugate anti-streptavidin (1:100, eBioscience Cat#25-
4317-82). Muscle satellite cells, identified as CD45- 
Sca-1- CD11b- Ter119-CXCR4+ β1-Integrin+ cell 
population as in previous studies [4,21,47,48].  Cells 
were sorted by Fluorescence Activated Cell Sorting 
(FACS) using Aria II (BD Biosciences). Live cells were 
identified as calcein blue positive (1:1000, Invitrogen) 
and propidium iodide negative (PI, 1mg/mL, Sigma 
Aldrich). Satellite cells were double-sorted to maximize 
the purity of sorted cells [4,21,47,48].  Previous studies 
have shown that >90% of CD45- Sca-1- Mac-1- 
CXCR4+ β1-integrin+ cells express Pax7, the canonical 
satellite cell marker, and that this marker profile 
identifies >98% of Pax7+ satellite cells [4,21,47,48,49].  
Flow cytometry and cell sorting were performed at the 
Joslin Diabetes Center or HSCRB Flow Cytometry 
Cores. Sorting and analysis were carefully optimized for 
antibody titration and to achieve maximal cell purity 
and viability [4,21,47,48]. 
 
Myogenic colony-forming assays 
 
A single CD45- Sca-1- Mac-1- CXCR4+ β1-integrin+ 
satellite cell was seeded in each well of a 96-well plate 
coated with PBS containing collagen (1mg/ml, Sigma) 
and laminin (10mg/ml, Invitrogen) for at least an hour 
at 37°C. Cells were cultured in F10 medium containing 
20% horse serum, 1% glutamax, and 1% Penstrep, and 
supplemented daily with 5ng/mL bFGF (Sigma 
Aldrich), as previously described [4,21,47]. Colony 
formation efficiency was analyzed on day 5 of culture 
and reported as the percent of seeded wells that 
contained cell colonies. The number of cells per colony 
was also quantified in some experiments. All cell 
colonies that arise in these assays are myogenic. No 
fibroblast or adipocyte colonies were detected or scored 
[4,21,47]. 
 
In vivo electroporation 
 
TA muscles subjected to in vivo electroporation were 
pre-conditioned by injection of 10 ul of 2 mg/ml 
hyaluronidase solution 1 hour prior to electroporation. 
A mixture of 50 pmol of siRNA (Life Technologies) 
and 30 µg of mCherry-expressing plasmid (Addgene) in 
10 ul of PBS was injected into the pre-conditioned TA 
muscles 10 minutes before electroporation. Following 
injection, electric pulses were delivered using an 
electric pulse generator (Electro Square porator ECM 
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830; BTX), by a pair of electrodes at the site of 
injection. Ten pulses were delivered, each with 20 ms 
duration at 1Hz. This procedure was repeated with 





For mRNA extraction, CD45- Sca-1- Mac-1- CXCR4+ 
β1-integrin+ satellite cells harvested from mouse skeletal 
muscle were double-sorted for purity, and deposited in 
Trizol (Invitrogen). For whole muscle mRNA, muscle 
was homogenized in Trizol using a Gentle MACS 
Dissociator (Miltenyi Biotech). cDNA was prepared 
from mRNA using Superscript III Reverse Trans-
criptase Supermix Kit (Invitrogen). Real-time 
quantitative PCR reactions were carried out in an ABI 
7900 machine, using SYBR Green PCR mix (Applied 
Biosystems). β-actin was used as a housekeeping gene, 
and gene expression levels were normalized to β-actin 
expression. Primers sequences are provided in 
Supplementary Table 2. 
 
Electrophoretic mobility shift assay (EMSA) 
 
All nuclear extraction procedures were performed on ice 
with ice-cold reagents. Nuclear protein was extracted 
using the Nuclear Extraction Kit (Panomics). Protein 
concentration of nuclear extract was measured using the 
DC Protein Assay (BioRad). Binding tests for 
transcription factors were performed as described by the 
manufacturer (Affymetrix). 10 μl of binding reaction 
mixtures containing 1 μg of poly(dI–dC) and 10 ng 
biotin-labeled transcription factor probe in binding 
buffer were incubated with 5 μg cell nuclear extracts at 
15 °C for 30 min, followed by fractionation on native 
5% TBE polyacrylamide gels, transfer to a nylon 
membrane, and detection by streptavidin HRP solution. 
Results were visualized by autoradiography and 
quantified using Image J densitometry. 
 
Cryoinjury of muscle and quantification of cross 
sectional area of regenerating myofibers 
 
For cryoinjury, mice were anesthetized and dry ice was 
applied directly to the exposed TA muscle for 5 
seconds. The skin incision was closed with suture 
immediately after injury. This procedure generates a 
reproducible injury in the muscle with a discrete border 
between uninjured and injured muscle, and this border 
remains clear and distinct during regeneration of the 
injured tissue [1,3,4,50]. Injured muscles were allowed 
to recover for 7 or 14 days before harvest. For 
quantification of regenerating myofiber size after 
cryoinjury, a series of pictures were taken spanning the 
entire regenerating area in cross section, and the sizes of 
15 regenerating myofibers (identified by their centrally 
located nuclei) were measured in each image, which 
collectively resulted in total of ~150 myofiber sizes 
measured for each animal using Axiovert software. 
 
RNA transcriptome analysis 
 
Total RNA was extracted from muscle tissue using 
Trizol (Invitrogen). RNA quality was assessed with a 
2100 Bioanalyzer (Agilent Technologies), and samples 
with RNA Integrity Number (RIN) higher than 8.5 were 
used. The total RNA samples were pre-processed using 
the GeneChip WT PLUS Reagent Kit (Affymetrix) 
following the manufacturer's protocol for hybridization 
to GeneChip Mouse Gene 2.0 ST Arrays (Affymetrix) 
by the Boston Children’s Hospital Intellectual and 
Developmental Disabilities Research Center (IDDRC) 
Molecular Genetics Core Facility.  The dataset was 
normalized by the robust multi-array average (RMA) 
algorithm [51] and analyzed with the R software 
(www.r-project.org). The dataset has been deposited at 
NCBI’s Gene Expression Omnibus (GEO) and are 
accessible through GEO Series accession number 
GSE72179. Genes which were expressed similarly in 
young WT and aged MISR mice, but differentially 
expressed in aged WT mice, were chosen based on fold-
change as candidates. Among candidates, genes found 
in the literature to have potential to mediate NF-κB 
signaling during inflammation were assayed by qRT-
PCR for validation (data not shown). Candidate genes 
validated for their expression pattern in muscle tissues 
of young and old WT and MISR mice are shown in 
Supplementry Table 1. In addition, candidate genes 
were also evaluated for NF-κB binding prediction index 
obtained by transcription factor binding site analysis by 
MatInspector computational software 
(www.genomatix.de). For NF-κB binding prediction 
index, “matrix similarity” between the promoter 
sequence of each candidate gene and the position 
weight matrices (the complete nucleotide distribution 
for each single position) of the DNA-binding motif of 
NF-κB was calculated by MatInspector as previously 
described [29]. A perfect match to the matrix gets a 
score of 1.00 (each sequence position corresponds to the 
highest conserved nucleotide at that position in the 




Harvested muscles were fixed in 4% paraformaldehyde, 
washed in PBS and stored in 70% ethanol for paraffin 
embedding, or frozen for cryo-sectioning (10μm 
sections). Hematoxylin and eosin (H&E) staining was 
used to visualize regenerating myofibers in injured 
muscles. 
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Microscopy 
 
Bright field images were acquired using Carl Zeiss 
Axiovert 40C and Carl Zeiss Observer D1 (Carl Zeiss 
Inc.). Fluorescence images were acquired using Carl 
Zeiss Axio Imager M1 (Carl Zeiss Inc.).  
 
Prostaglandin E2 ELISA 
 
Muscle extract samples for ELISA were obtained by 
homogenizing quadriceps muscles of young and aged 
mice in homogenization buffer (0.1 M phosphate, pH 7.4, 
containing 1mM EDTA and 1uM indomethacin). 
Prostaglandin E2 ELISA was performed according the 





Data are presented as mean ± standard error of mean 
(s.e.m.). For all graphic data, n indicates the number  
of  biological replicates. The number of animals used 
per group was determined based on accumulated 
empirical data in the laboratory and anticipated 
robustness of the data points [4,21,47].  The number of 
animals for each experiment was appropriate to detect 
the differences, if present, in the experimental 
outcomes. For salicylate feed treatment and pla2g5 
knockdown experiments, animals were randomly 
allocated for different treatment conditions. Animals 
diagnosed with severe health concerns (tumors, 
malocclusion, etc.) by veterinary staff were excluded 
from analysis; this exclusion criterion was pre-
determined. Data were tested for normal distribution, 
and the observed variation was similar between groups. 
Statistical comparisons for normally distributed data 
were performed using appropriate tests, as indicated 
below. Results comparing two different groups were 
assessed for statistical significance using Student’s t test 
(Microsoft Excel; GraphPad Prism, GraphPad Software 
Inc.) assuming two-tailed distribution (Figure 1H,I; 
Figure 2E; Figure 3D,G; Figure 4A,B) and results 
comparing more than two groups were assessed by one-
way ANOVA with Turkey’s multiple comparison test 
(GraphPad Prism, GraphPad Software Inc.; Figure 
1B,F,G; Figure 2D; and Figure 3A,B). For statistical 
analyses of distribution and average of regenerating 
myofiber sizes in injured muscles, p-values were 
calculated by Kruskal-Wallis test and adjusted, if 
necessary, by Stepdown-Bonferroni method (Figure 
1C,D; Figure 2A,B; Figure 3F,G; and Figure 4D,E). 
Investigators were blinded to experimental group 
assignment for outcome assessment. Statistical 
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